Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research interests include Biology, Medicine, Endometrial cancer, Oncology, Ovarian cancer, and Genome-wide association study.
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix
Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas
A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease
Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma
Fertility-sparing treatment in early endometrial cancer: current state and future strategies
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer
Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study
Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations
Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC
Poor outcome in hypoxic endometrial carcinoma is related to vascular density
Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study
Identification of nine new susceptibility loci for endometrial cancer
Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses
Patient-Derived Xenograft Models for Endometrial Cancer Research
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology
Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Genome-wide significant risk associations for mucinous ovarian carcinoma
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer
Network-Based Integration of GWAS and Gene Expression Identifies a <i>HOX</i> -Centric Network Associated with Serous Ovarian Cancer Risk
Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
Common variants at the<i>CHEK2</i>gene locus and risk of epithelial ovarian cancer
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study
Landscape of genomic alterations in cervical carcinomas